Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: ofloxacin incorporated t-prf(titanium prf): 0.5ml of Ofloxacin to 5ml of blood sample will be taken in the titanium tubes and then it will be subjected to centrifugation at 3500rpm for
Sponsors
Dr Sarvapradha S S
Eligibility
Inclusion criteria
Inclusion criteria: 1.Moderate periodontitis with attachment loss of 3 4 mm probing depth less than or equal to 6 and bleeding on probing 2.Systemically healthy patients 3.Patients age from 25-50 years 4.No history of periodontal therapy, either surgical or non-surgical in the previous six months. 5.Patient who have agreed to participate in the study
Exclusion criteria
Exclusion criteria: 1.Smokers 2.Pregnancy and lactating women 3.Systemic and debilitating diseases 4.Use of antibiotics during the last six months. 5.A previous unfavourable response to the study s products. 6.Patients with bleeding disorders 7.Patients taking antiplatelet therapy and anticoagulant therapy 8.Patients with severe hepatic impairment or renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the clinical efficacy of scaling and root planing (SRP) alone and in combination with ofloxacin-incorporated and metronidazole-incorporated titanium-prepared platelet-rich fibrin (T-PRF) as adjuncts in non-surgical periodontal therapyTimepoint: Baseline, 1 month, 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare and analyze the clinical outcomes of SRP alone, SRP with ofloxacin-incorporated T-PRF, and SRP with metronidazole-incorporated T-PRF in non-surgical periodontal therapy Timepoint: Baseline, 1 month, 3 months | — |
Countries
India
Contacts
Public ContactDr Prakash Pai G
KVG Dental College and Hospital
Outcome results
None listed